Simplex Trading’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-100
| Closed | -$30.4K | – | 10430 |
|
|
2025
Q4 | $30.4K | Sell |
100
-2,600
| -96% | -$851K | ﹤0.01% | 6097 |
|
|
2025
Q3 | $919K | Buy |
2,700
+2,300
| +575% | +$698K | ﹤0.01% | 3142 |
|
|
2025
Q2 | $96K | Sell |
400
-1,000
| -71% | -$245K | ﹤0.01% | 5283 |
|
|
2025
Q1 | $381K | Sell |
1,400
-1,400
| -50% | -$327K | ﹤0.01% | 3693 |
|
|
2024
Q4 | $9K | Buy |
2,800
+2,200
| +367% | +$449K | ﹤0.01% | 7292 |
|
|
2024
Q3 | $134K | Sell |
600
-1,400
| -70% | -$252K | ﹤0.01% | 4936 |
|
|
2024
Q2 | $285K | Sell |
2,000
-2,300
| -53% | -$354K | ﹤0.01% | 4298 |
|
|
2024
Q1 | $672K | Buy |
4,300
+2,300
| +115% | +$370K | ﹤0.01% | 3535 |
|
|
2023
Q4 | $360K | Sell |
2,000
-1,300
| -39% | -$235K | ﹤0.01% | 4038 |
|
|
2023
Q3 | $593K | Sell |
3,300
-4,300
| -57% | -$851K | ﹤0.01% | 3221 |
|
|
2023
Q2 | $1.35M | Buy |
7,600
+2,200
| +41% | +$507K | ﹤0.01% | 2315 |
|
|
2023
Q1 | $1.16M | Buy |
5,400
+1,800
| +50% | +$432K | ﹤0.01% | 2455 |
|
|
2022
Q4 | $791K | Buy |
+3,600
| New | +$660K | ﹤0.01% | 2699 |
|
|
2022
Q3 | – | Sell |
-100
| Closed | -$16K | – | 11075 |
|
|
2022
Q2 | $16K | Sell |
100
-700
| -88% | -$109K | ﹤0.01% | 7850 |
|
|
2022
Q1 | $150K | Sell |
800
-500
| -38% | -$106K | ﹤0.01% | 5587 |
|
|
2021
Q4 | $352K | Sell |
1,300
-1,200
| -48% | -$405K | ﹤0.01% | 4324 |
|
|
2021
Q3 | $874K | Hold |
2,500
| – | – | ﹤0.01% | 3267 |
|
|
2021
Q2 | $857K | Buy |
2,500
+2,458
| +5,852% | +$814K | ﹤0.01% | 3348 |
|
|
2021
Q1 | $1.46M | Buy |
42
+13
| +45% | +$4.3K | ﹤0.01% | 1967 |
|
|
2020
Q4 | $749K | Buy |
+29
| New | +$7.98K | ﹤0.01% | 2922 |
|
|
2020
Q2 | – | Sell |
-22
| Closed | -$270K | – | 8526 |
|
|
2020
Q1 | $270K | Sell |
22
-79
| -78% | -$12.4K | ﹤0.01% | 3254 |
|
|
2019
Q4 | $1.67M | Sell |
101
-127
| -56% | -$21.1K | ﹤0.01% | 1634 |
|
|
2019
Q3 | $2.79M | Buy |
228
+225
| +7,500% | +$29.9K | 0.01% | 1068 |
|
|
2019
Q2 | $37K | Buy |
3
+1
| +50% | +$127 | ﹤0.01% | 5115 |
|
|
2019
Q1 | $26K | Buy |
2
+1
| +100% | +$135 | ﹤0.01% | 5544 |
|
|
2018
Q4 | $14K | Sell |
1
-31
| -97% | -$4.11K | ﹤0.01% | 5633 |
|
|
2018
Q3 | $551K | Sell |
32
-15
| -32% | -$2.52K | ﹤0.01% | 2531 |
|
|
2018
Q2 | $722K | Buy |
47
+31
| +194% | +$5.53K | ﹤0.01% | 2099 |
|
|
2018
Q1 | $4K | Buy |
+16
| New | +$2.17K | ﹤0.01% | 4859 |
|
|
2017
Q4 | – | Sell |
-11
| Closed | -$2K | – | 6834 |
|
|
2017
Q3 | $2K | Buy |
+11
| New | +$820 | ﹤0.01% | 5194 |
|
Other funds holding ONC
BBA
HA
Simplex Trading's ONC Position: Q3 2025 in Review
Simplex Trading sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 503 shares — an estimated $153K sold.
Simplex Trading first reported a position in ONC in Q3 2017 and held it in 21 quarters. The position peaked at $1.28M in Q3 2020. 265 funds tracked by Wall St. Rank hold ONC as of Q3 2025.
- Simplex Trading reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 503 BeOne Medicines Ltd shares in Q3 2025, an estimated $153K.
- Simplex Trading first reported a position in BeOne Medicines Ltd in Q3 2017 and held it in 21 quarters.
- Simplex Trading's BeOne Medicines Ltd position peaked at $1.28M in Q3 2020.
- 265 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.